Quick Takeaways
- GSK plc reports institutional holdings through Form 13F filings.
- Latest reported quarter: Q4 2025.
- Latest reported holdings value: $799,022,938.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Financials
- Holders: GSK, G3910J179
13F Filings History of GSK plc
- Latest 13F report
- Q4 2025 - 12 Feb 2026
- Value $
- $799,022,938
- Signature - Title
- Victoria Whyte - Authorised Signatory for and on behalf of GSK plc
- Location
- London
- Summary
- This page shows a list of all the recent 13F filings made by GSK plc. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GSK plc reported 15 stock holdings with total value $799,022,938 as of Q4 2025. Top holdings included WVE, CRSP, BNTX, VIR, and LYEL.
Follow Filing Activity
Follow GSK plc and return when a new 13F portfolio filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Holdings Value
What Changed
- Most recent filing was accepted on 12 Feb 2026, 16:29.
- Historical comparison will expand as more 13F quarters are available.
Why This Matters
- This gives a plain-language read of holdings direction before you open full quarter tables.
- Use the filing links below to verify the exact SEC source document.
Official SEC Source
Backed by Form 13F
Portfolio holdings and changes are grounded in SEC Form 13F filings.
See Original Filing| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 15 | $799,022,938 | $0 | $0 | $0 | WVE, CRSP, BNTX, VIR, LYEL | 13F-HR | 12 Feb 2026, 16:29 |